Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harald Seeger

Showing results (51-60 of 146) with videos related to

Pageof 15
Sort By:
European Journal of Obstetrics, Gynecology, and Reproductive Biology|February 8, 2006
The effect of progesterone, testosterone and synthetic progestogens on growth factor- and estradiol-treated human cancerous and benign breast cellsElizabeth A Krämer, Harald Seeger, Bernhard Krämer, et al.
Praxis|December 11, 2025
[Kidney care indicator set for measuring kidney care in primary care in Switzerland]Levy Jäger, Leander Muheim, Christian Häuptle, et al.
The Journal of Steroid Biochemistry and Molecular Biology|January 18, 2006
Characterization of the stimulatory effect of medroxyprogesterone acetate and chlormadinone acetate on growth factor treated normal human breast epithelial cellsElizabeth A Krämer, Harald Seeger, Bernhard Krämer, et al.
Menopause (New York, N.Y.)|July 23, 2005
The effects of progesterone, medroxyprogesterone acetate, and norethisterone on growth factor- and estradiol-treated human cancerous and noncancerous breast cellsElizabeth A Krämer, Harald Seeger, Bernhard Krämer, et al.
Investigational New Drugs|December 10, 2009
ATP chemosensitivity testing of new antitumor duplex drugs linking 3`-C-ethynylycytidine (ECyd) and 2´-deoxy-5-fluorouridine (5-FdU) in comparison to standard cytostatica and combinations thereofSarah Schott, Markus Wallwiener, Beate Kootz, et al.
Menopause (New York, N.Y.)|June 28, 2007
Low-dose continuous combinations of hormone therapy and biochemical surrogate markers for vascular tone and inflammation: transdermal versus oral applicationAlfred O Mueck, Andrea R Genazzani, Göran Samsioe, et al.
Biologicals : Journal of the International Association of Biological Standardization|September 2, 2008
Prion depletion and preservation of biological activity by preparative chaotrope ultracentrifugationHarald Seeger, Christian Julius, Costantino Cozzari, et al.
Journal of Telemedicine and Telecare|July 11, 2009
Impact of electronic messaging on the patient-physician interactionMarkus Wallwiener, Christian Wilhelm Wallwiener, Julia Katharina Kansy, et al.
Biomed Research International|October 24, 2015
The potential role of NFAT5 and osmolarity in peritoneal injuryHarald Seeger, Daniel Kitterer, Joerg Latus, et al.
Investigative Radiology|May 22, 2002
Endothelin A receptor antagonist LU 135252 inhibits hypercholesterolemia-induced, but not deendothelialization-induced, atherosclerosis in rabbit arteriesGunnar Tepe, Ute Brehme, Harald Seeger, et al.
Pageof 15

Showing results (51-60 of 146) with videos related to

Sort By:
Pageof 15
European Journal of Obstetrics, Gynecology, and Reproductive Biology|February 8, 2006
The effect of progesterone, testosterone and synthetic progestogens on growth factor- and estradiol-treated human cancerous and benign breast cellsElizabeth A Krämer, Harald Seeger, Bernhard Krämer, et al.
Praxis|December 11, 2025
[Kidney care indicator set for measuring kidney care in primary care in Switzerland]Levy Jäger, Leander Muheim, Christian Häuptle, et al.
The Journal of Steroid Biochemistry and Molecular Biology|January 18, 2006
Characterization of the stimulatory effect of medroxyprogesterone acetate and chlormadinone acetate on growth factor treated normal human breast epithelial cellsElizabeth A Krämer, Harald Seeger, Bernhard Krämer, et al.
Menopause (New York, N.Y.)|July 23, 2005
The effects of progesterone, medroxyprogesterone acetate, and norethisterone on growth factor- and estradiol-treated human cancerous and noncancerous breast cellsElizabeth A Krämer, Harald Seeger, Bernhard Krämer, et al.
Investigational New Drugs|December 10, 2009
ATP chemosensitivity testing of new antitumor duplex drugs linking 3`-C-ethynylycytidine (ECyd) and 2´-deoxy-5-fluorouridine (5-FdU) in comparison to standard cytostatica and combinations thereofSarah Schott, Markus Wallwiener, Beate Kootz, et al.
Menopause (New York, N.Y.)|June 28, 2007
Low-dose continuous combinations of hormone therapy and biochemical surrogate markers for vascular tone and inflammation: transdermal versus oral applicationAlfred O Mueck, Andrea R Genazzani, Göran Samsioe, et al.
Biologicals : Journal of the International Association of Biological Standardization|September 2, 2008
Prion depletion and preservation of biological activity by preparative chaotrope ultracentrifugationHarald Seeger, Christian Julius, Costantino Cozzari, et al.
Journal of Telemedicine and Telecare|July 11, 2009
Impact of electronic messaging on the patient-physician interactionMarkus Wallwiener, Christian Wilhelm Wallwiener, Julia Katharina Kansy, et al.
Biomed Research International|October 24, 2015
The potential role of NFAT5 and osmolarity in peritoneal injuryHarald Seeger, Daniel Kitterer, Joerg Latus, et al.
Investigative Radiology|May 22, 2002
Endothelin A receptor antagonist LU 135252 inhibits hypercholesterolemia-induced, but not deendothelialization-induced, atherosclerosis in rabbit arteriesGunnar Tepe, Ute Brehme, Harald Seeger, et al.
Pageof 15